AstraZeneca Loses Bid For India Patent On New Prilosec Formulation (India)
This article was originally published in PharmAsia News
Executive Summary
Indian authorities have denied AstraZeneca a patent for a new formulation of its Prilosec (omeprazole) drug for treating ulcers. Indian drug maker Torrent Pharma had filed opposition to the patent. The Delhi patent office said it rejected the patent requiest because the new formulation did not provide enhanced therapeutic efficacy to the already-patented formulation. Generics of the drug have been available in India for several years. (Click here for more